Halozyme Therapeutics shares owned by Portside Wealth Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Portside Wealth Group
from 13F filings
Historical chart of Portside Wealth Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Portside Wealth Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Portside Wealth Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $522k | 9.1k | 57.24 |
| 2024-06-30 | $206k | 3.9k | 52.36 |
| 2023-09-30 | $214k | 5.6k | 38.21 |
| 2023-06-30 | $4.9M | 137k | 36.07 |